All active MDLs
MDL 2996Personal Injury

McKinsey & Company, Inc., National Prescription Opiate Consultant Litigation

McKinsey's alleged role in the opioid epidemic involved strategic consulting that promoted aggressive marketing of opioids as safe and non-addictive, influencing prescriber behavior and increasing prescriptions. This led to widespread misuse, addiction, and overdose deaths. The pathways of harm include targeted marketing to healthcare providers, setting sales targets, and minimizing perceived risks, which collectively contributed to the public health crisis.

CANSr. District Judge Charles R. BreyerMaster docket 3:21-md-2996Source: JPML · Updated March 24, 2026

235

Pending actions

262

Total actions filed

Active

Status

06/07/2021

Established

Who qualifies

Plaintiffs must demonstrate injury linked to opioid use or overdose, with evidence such as medical records, prescriptions, and expert testimony. Exposure during specific periods, typically post-2010, and a causal connection to McKinsey's consulting advice are required.

Products involved

  • Prescription opioids
  • OxyContin

Alleged injuries

  • Addiction
  • Overdose
  • Dependency

This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.

MDL Match

Your next intake could have a mass tort hiding in it.

Screen it against 158+ active MDLs. Takes under 60 seconds.

Start matching now